Potassium Phosphates Solution, Concentrate
Product Images NDC 80830-1691

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Potassium Phosphates (NDC 80830-1691). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Potassium Phosphates Injection Novaplus 1)

FDA Label Image

2 (Potassium Phosphates Injection Novaplus 2)

FDA Label Image

3 (Potassium Phosphates Injection Novaplus 3)

FDA Label Image

2 (Potassium Phosphates Injection Novaplus 4)

FDA Label Image

5 (Potassium Phosphates Injection Novaplus 5)

This text contains information regarding Potassium Phosphates Injection, USP, including dosage recommendations, storage instructions, and details on the manufacturer and distributor. The injection is intended for intravenous use only and must be diluted before administration. It is presented in single-dose vials and is sterile, nonpyrogenic, and preservative-free. The text also mentions the trademarks associated with the product and provides specific details about the content of each mL of the injection.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.